L-pampo

Class [005]
Vaccines for cattle; Oral vaccine preparations for animals; Oral vaccine preparations for human use; veterinary vaccines; Human vaccines and Veterinary vaccines ; Human vaccines; Veterinary vaccines; adjuvants for use with vaccines; Human vaccine preparations; Veterinary vaccine preparations; Veterinary substances and preparations for treating and preventing animal diseases, cattle diseases, sheep/goat diseases and avian diseases namely foot and mouth disease, rabies, West Nile Virus infection, bovine viral diarrhea, sheep pox and goat pox, avian influenza, fowl pox, leptospirosis and Q fever; human vaccine preparations; anti-microbial preparations for treating and preventing viruses and infectious diseases namely tuberculosis, pneumonia, cold, whooping cough, measles, stomach flu; pharmaceutical and biological preparations or composition for the treatment and prevention of infectious diseases, namely, respiratory infections, eye infections, topical infections, genetic diseases, neurological disease, autoimmune diseases, and cancers; pharmaceutical compositions for the treatment and prevention of virus or bacteria-derived infectious diseases and inflammations, genetic diseases, neurological diseases, autoimmune diseases, and cancers; diagnostic reagents for medical use; reagents for use in medical testing for autoimmune diseases and disorders; diagnostic reagents for medical use; veterinary diagnostic reagents; clinical diagnostic reagents; hepatitis vaccine; preparations for treatment of hepatitis; vaccines against flu; Immunostimulants namely cytokines, chemokines, growth factors, and TLR ligands for the therapeutic treatment of infectious diseases and cancers in animals and humans; pharmaceutical preparations for use in immunomodulation therapies; pharmaceutical preparations for regulating the immune system namely innate immune cells and adaptive immune cells; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for viral diseases namely influenza, herpes virus infection, viral hepatitis, and human immunodeficiency virus (HIV); veterinary vaccines for bovine animals; veterinary vaccines for sheep; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of lung, colorectal, ovarian, prostate, pancreatic and head and neck cancers; pharmaceutical products for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat infectious diseases and cancers; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, rheumatoid arthritis, Type 1 diabetes, inflammatory bowel diseases, multiple sclerosis and autoimmune hepatitis; anti-infectives; anti-viral agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; biopharmaceuticals for the treatment of cancer; biological preparations derived from human immune systems for the treatment of cancer; immunostimulators namely cytokines, chemokines or TLR ligands; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer; pharmaceutical preparations and substances for the prevention of cancer